...
首页> 外文期刊>JK Science : Journal of Medical Education & Research >Aprepitant- A Novel Drug to Prevent Cancer Chemotherapy Induced Nausea and Vomiting
【24h】

Aprepitant- A Novel Drug to Prevent Cancer Chemotherapy Induced Nausea and Vomiting

机译:Aprepitant-一种预防癌症化疗引起的恶心和呕吐的新药

获取原文
           

摘要

Nausea and vomiting are common and distressing side effects of the chemotherapy. However, the drugs used for chemotherapy vary in the extent to which they cause nausea and vomiting. Highly emetogenic drugs like cisplatin result in severe nausea in most patients as compared to moderately emetogenic ones. Agents commonly used for the treatment of chemotherapy induced vomiting include dopamine antagonists, 5HT3 antagonist and corticosteroids (1). Search for the novel agents has led to the development of Aprepitant, which is a neurokinin 1 receptor blocker
机译:恶心和呕吐是化疗的常见和令人痛苦的副作用。但是,用于化疗的药物在引起恶心和呕吐的程度上有所不同。与中度致呕药相比,大多数患者的严重致呕药如顺铂会导致严重的恶心。通常用于治疗化学疗法引起的呕吐的药物包括多巴胺拮抗剂,5HT3拮抗剂和皮质类固醇(1)。寻找新型药物导致了Aprepitant的发展,Aprepitant是一种神经激肽1受体阻滞剂

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号